Pfizer Inc.
Stability-modulating linkers for use with antibody drug conjugates

Last updated:

Abstract:

The present invention provides stability-modulated antibody-drug conjugates, stability-modulating linker components used to make these stability-modulated antibody-drug conjugates, therapeutic methods using stability-modulated antibody-drug conjugates, and methods of making stability modulating linkers and stability-modulated antibody-drug conjugates.

Status:
Grant
Type:

Utility

Filling date:

14 Aug 2015

Issue date:

6 Apr 2021